Cooper A.r. .5 mg Drops is a Health Canada–registered human drug (DIN 02174243) held by Coopervision Inc., containing Naphazoline Hydrochloride. Health Canada lists its status as Cancelled Post Market (status date 12 Mar 1998). Nexara Health has matched 60 registrations of Naphazoline Hydrochloride across 10 other regulated markets.
Health Canada registration
| DIN | 02174243 |
|---|---|
| Brand name | Cooper A.r. |
| Active ingredient | Naphazoline Hydrochloride |
| Strength | .5 mg |
| Dosage form | Drops |
| Route | Ophthalmic |
| Company | Coopervision Inc. |
| Status | Cancelled Post Market — 12 Mar 1998 |
| Class | Human |
| ATC | |
| AHFS | 04:04.08 |
| Regulator record | Health Canada DPD entry · Product monograph |
Naphazoline Hydrochloride registered in other markets
60 registrations of the same molecule in 10 national registries outside Canada (first 39 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Austria | Aconex Augentropf. | — | 10ml | green box | eEKO (Erstattungskodex) | |
| Austria | Coldophthal Augentropf. | — | 10ml | green box | eEKO (Erstattungskodex) | |
| Bahrain | Riazolin | Riyadh Pharma (Medical And Cosmetic Product Co. Ltd), Ksa. | 0.1 % W/V | Eye Drops | POM | NHRA |
| Hong Kong | Coldan Eye Drops 0.1% | Fortune National (Hong Kong) Limited | Registered | DH Drug Office | ||
| Hong Kong | Coldan Nose Drops 0.1% | Fortune National (Hong Kong) Limited | Registered | DH Drug Office | ||
| Hong Kong | Dropnalin Eye Drops 0.1% | Sheraton Worldwide Drugs Co Ltd | Registered | DH Drug Office | ||
| Hong Kong | Naftdrop Eye Drops 0.1% | Sheraton Worldwide Drugs Co Ltd | Registered | DH Drug Office | ||
| Hong Kong | Naphazoline Eye/Nose Drops 0.05% | Jean-Marie Pharmacal Co Ltd | Registered | DH Drug Office | ||
| Hong Kong | Rino-Naftazolina Nasal Drops 0.2% | Sheraton Worldwide Drugs Co Ltd | Registered | DH Drug Office | ||
| Hong Kong | Rino-Naftazolina Nasal Spray 0.2% | Sheraton Worldwide Drugs Co Ltd | Registered | DH Drug Office | ||
| Hong Kong | Rohto Lycee Eye Drops 0.012% | Mentholatum (Asia Pacific) Limited | Registered | DH Drug Office | ||
| Ireland | Murine irritation & redness relief, 0.012% w/v, eye drops solution | Elara Pharmaservices Europe Limited | Eye drops, solution | Marketed | HPRA | |
| Saudi Arabia | Albalon Eye Drops 0.1% | — | 0.1 | Inactive | SFDA | |
| Saudi Arabia | Apizolin 0.1% Eye Drop | — | 0.1 | Inactive | SFDA | |
| Saudi Arabia | Konjunctival Eye Drops | — | 0.1 | Inactive | SFDA | |
| Saudi Arabia | Murine Eye Drops | — | 0.012 | Inactive | SFDA | |
| Saudi Arabia | Naphcon Forte 0.1% Eye Drops | — | 0.1 | Inactive | SFDA | |
| Saudi Arabia | Seretide Evohaler | — | 250,25 | Active | SFDA | |
| South Africa | Safyr Bleu Eye Drops | Pharmacare Limited, Woodmead | 0.5 mg/ml | Opd | S2 | DoH SEP database |
| South Africa | Safyr Bleu Eye Drops | Pharmacare Limited, Woodmead | 0.5 mg/ml | Opd | S2 | DoH SEP database |
| South Africa | Safyr Bleu Eye Drops | Pharmacare Limited, Woodmead | 0.5 mg/ml | Opd | S2 | DoH SEP database |
| Taiwan | Albalon Liquifilm Ophthalmic Solution 0.1% | Allergan Pharmaceuticals Ireland | 點眼液劑 | 已註銷 | TFDA | |
| Taiwan | B.p.a. Liq. | 依必朗化學製藥股份有限公司 | 點鼻液劑 | 已註銷 | TFDA | |
| Taiwan | Murine Clear Eyes | Abott Australasia Pty Ltd. | 點眼液劑 | 已註銷 | TFDA | |
| Taiwan | Naphazoline HCl | Archemia S.p.a. | （粉） | 已註銷 | TFDA | |
| Taiwan | Naphazoline HCl | A.m.s.a. Anonima Materie Sintetiche & Affini S.p.a. | （粉） | 已註銷 | TFDA | |
| Taiwan | Naphazoline HCl | A.m.s.a. Anonima Materie Sintetiche & Affini S.p.a. | （粉） | 已註銷 | TFDA | |
| Taiwan | Naphazoline HCl "Huth" | Claus Huth Georgsplatz La. | （粉） | 已註銷 | TFDA | |
| Taiwan | Naphazoline HCl "Yamanouchi" | Yamanouchi Pharmaceutical Co. Ltd. | （粉） | 已註銷 | TFDA | |
| United Arab Emirates | Clear eyes® REDNESS RELIEF | ASPEN SVP (Pty) Ltd., South Africa, Port Elizabeth | 0.012 %w/v | Drops | Active | EDE |
| United Kingdom | Naphazoline 0.012% eye drops | — | 0001 | NHS dm+d VMP | ||
| United States | Doctor Jiao Nasal Decongestant | Jiangxi Haiwei Pharmaceutical Co., Ltd. | Spray | FDA NDC | ||
| United States | Nafasolina | Doral Pharmamedics Inc DBA AG Marin Pharmaceuticals | Solution/ Drops | listed | FDA NDC | |
| United States | Naphazoline hydrochloride | Biophore India Pharmaceuticals Pvt. Ltd | Powder | FDA NDC | ||
| United States | Naphazoline Hydrochloride | C-Squared Pharma Limited | Powder | FDA NDC | ||
| United States | Naphazoline Hydrochloride | Micro Labs Limited | Powder | FDA NDC | ||
| United States | Naphazoline Hydrochloride | Loba biotech GmbH | Powder | FDA NDC | ||
| United States | Naphazoline Hydrochloride | Haleos Labs Limited | Powder | FDA NDC | ||
| United States | Nazal | Sato Pharmaceutical Co., Ltd. | Liquid | listed | FDA NDC |
See every manufacturer of Naphazoline Hydrochloride worldwide →
Regulator price references for Naphazoline Hydrochloride
Published list or reimbursement prices for Naphazoline Hydrochloride presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Austria | Coldophthal Augentropf. | 10ml | 10ml | 3.95 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Aconex Augentropf. | 10ml | 10ml | 6.85 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Bahrain | Riazolin | 0.1pct | 15ML | 1.64 BHD | retail (max) | NHRA | 2026-09-01 |
| Saudi Arabia | Murine Eye Drops | 3.70 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Apizolin 0.1% Eye Drop | 0.1pct | 3.85 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Konjunctival Eye Drops | 11.90 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Albalon Eye Drops 0.1% | 0.1pct | 14.60 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Naphcon Forte 0.1% Eye Drops | 0.1pct | 17.30 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Zymar 0.3% Ophthalmic Solution | 28.35 SAR | public | SFDA | 2026-09-01 | ||
| South Africa | Safyr Bleu Eye Drops | 0.5mg/1ml | 5 | 24.85 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Safyr Bleu Eye Drops | 0.5mg/1ml | 10 | 49.71 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Safyr Bleu Eye Drops | 0.5mg/1ml | 15 | 74.55 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| United Arab Emirates | Clear eyes® REDNESS RELIEF | 15 ml HDPE Bottle | 25.00 AED | public | EDE | 2026-08-31 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Cooper A.r. (DIN 02174243) marketed in Canada?
No. Health Canada lists DIN 02174243 as Cancelled Post Market as of 12 Mar 1998.
Who holds the Canadian licence for this product?
Coopervision Inc. is the company of record in the Health Canada Drug Product Database.
Is Naphazoline Hydrochloride registered outside Canada?
Yes — Nexara Health has matched 60 registrations in 10 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02174243, status date 1998-03-12; national medicine registries: DH Drug Office, DoH SEP database, EDE, eEKO (Erstattungskodex), FDA NDC, HPRA, NHRA, NHS dm+d VMP, SFDA, TFDA; price sources: DoH SEP database, EDE, eEKO (Erstattungskodex), NHRA, SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02174243, status date 1998-03-12; national medicine registries: DH Drug Office, DoH SEP database, EDE, eEKO (Erstattungskodex), FDA NDC, HPRA, NHRA, NHS dm+d VMP, SFDA, TFDA; price sources: DoH SEP database, EDE, eEKO (Erstattungskodex), NHRA, SFDA.
Health Canada Drug Product Database (DPD), DIN 02174243, status date 1998-03-12; national medicine registries: DH Drug Office, DoH SEP database, EDE, eEKO (Erstattungskodex), FDA NDC, HPRA, NHRA, NHS dm+d VMP, SFDA, TFDA; price sources: DoH SEP database, EDE, eEKO (Erstattungskodex), NHRA, SFDA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.